WASHINGTON, Oct. 24, 2017 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will
release results for the third quarter of 2017 on Tuesday, November 7, 2017, after the market
closes.
Vanda will host a conference call at 4:30
PM ET on Tuesday, November 7,
2017, during which management will discuss the third quarter
2017 financial results and other corporate activities. To
participate in the conference call, please dial 1-888-771-4371
(domestic) or 1-847-585-4405 (international) and use passcode
45886211.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Tuesday, November 7, 2017, beginning at
7:00 PM ET and will be accessible
until Tuesday, November 14, 2017, at
11:59 PM ET. The replay call-in
number is 1-888-843-7419 for domestic callers and 1-630-652-3042
for international callers. The passcode number is
45886211.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global
biopharmaceutical company focused on the development and
commercialization of innovative therapies to address high unmet
medical needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:
Jim
Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2017-financial-results-on-november-7-2017-300541649.html
SOURCE Vanda Pharmaceuticals Inc.